Wednesday, January 25, 2006


Hep C Virus - AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus


AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus
Genetic Engineering News - AVI BioPharma, Inc. (Nasdaq:AVII), today announced publication of significant research carried out in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The report, published today in Public Library of

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral
Aidsmap - Prolonged high HIV viral loads are associated with an increased risk of non-Hodgkin's lymphoma (NHL) independent of CD4 cell counts, according to data from the French Aquitaine Cohort published in the February 1 st edition of Clinical Infectious